Nichi-Iko Pharmaceutical Co., Ltd.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Nichi-Iko Pharmaceutical Co., Ltd.
Nichi-Iko Pharmaceutical Co., Ltd. (日医工株式会社, 4541). 17 cross-shareholdings, a board of 10 and 10 largest shareholders, as filed on EDINET for the year to March 2022. EDINET filing S100OLZH, filed 2022-06-30. Source: company filings on EDINET (Financial Services Agency of Japan).
Cross-shareholdings
| Company held | Shares | Book value (¥bn) | % of shares outstanding |
|---|---|---|---|
| MEDIPAL HOLDINGS CORPORATION | 468,050 | 0.9 | 0.2 |
| Hokuhoku Financial Group, Inc. | 164,165 | 0.1 | 0.1 |
| Ｐｈａｒｍａｒｉｓｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | 150,000 | 0.1 | 1.6 |
| The Fukui Bank, Ltd. | 57,318 | 0.1 | 0.2 |
| VITAL KSK HOLDINGS,INC. | 102,425 | 0.1 | 0.2 |
| The Bank of Toyama,Ltd. | 24,800 | 0.1 | 0.5 |
| TOHO HOLDINGS CO.,LTD. | 19,291 | 0.0 | 0.0 |
| MITANI SANGYO CO.,LTD. | 57,420 | 0.0 | 0.1 |
| HOKUYAKU TAKEYAMA Holdings,Inc. | 23,240 | 0.0 | 0.1 |
| ASAHI PRINTING CO.,LTD. | 8,316 | 0.0 | 0.0 |
% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown